Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...
Health Minister defends emergency care outsourcing agreement, rejects doctors’ union’s claim it was not consulted and says ...
The global Oligonucleotide CDMO Market, valued at US$2.33 billion in 2023, is forecasted to grow at a robust CAGR of 21.8%, reaching US$2.51 billion in 2024 and an impressive US$6.73 billion by 2029.
BofA Securities maintained an Underperform rating on shares of Hims & Hers Health, Inc. (NYSE:HIMS) with a steady price ...
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 472.57% and ...
Health systems will seek to expand their supply chains and partnerships in 2025, while trimming excessive AI programs and nonclinical staff.
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
The Medical Association of Malta raises concerns about government’s refusal to hold proper discussions as trade dispute ...
It is most reassuring to see that in a very progressive and affirmative step in the right direction we see that none other ...
Indian outsourcing giant Infosys Ltd. on Thursday raised its sales outlook for the third time this year as the company said clients were increasingly adopting its artificial-intelligence services.